Study at a glance
Does a higher antibody level after vaccination prove lasting protection?
Antibodies are proteins the immune system uses to recognise targets. A higher level after vaccination describes one part of the response at that time. It does not establish protection years later or the response to a future exposure.
Is a booster response the same as creating new immune memory?
No. A booster builds on earlier immune experience. Antibody levels and memory cells, which help the body respond again, are related but separate measurements.
Do these vitamin D studies prove stronger immune memory in people?
They do not establish a broad benefit. The studies used different vaccine timings, skin responses and animal models. A short-term change cannot stand in for demonstrated long-term protection.
Read the full article below ↓A response after vaccination and a response to something encountered years earlier are related, but they answer different questions. Vitamin D studies become easier to interpret when the stages are kept separate: an initial response, a later recall response, and persistence over time. This page connects those stages without treating one measurement as proof of the others.
From the first encounter to a later response
Vitamin D and Adaptive Immunity introduces the targeted immune system. An antigen is a substance recognised by that system. Researchers can measure antibodies during a vaccine course, but that result describes the response at the testing point. It does not establish how the person will respond after a long interval or whether protection will persist.
Kashi and colleagues’ hepatitis B trial illustrates the timing problem. Vitamin D treatment started after the first vaccine dose, and antibodies were assessed before the final dose of the course. The study therefore cannot answer every question about vitamin D before first exposure or after a completed course. Its finding that did not show a treatment benefit still matters for the actual conditions tested. Untested timing is a gap, not evidence of a benefit at another time.
A booster tests an existing immune history
A booster is an additional vaccine dose given after earlier vaccination. Heine and colleagues’ small tetanus study found a difference in one antibody measure after a booster, without matching benefits in measured memory B cells or several other outcomes. Memory B cells retain information relevant to a later response. Their frequency and the amount of circulating antibody are related but different measurements.
The study did not follow people for five or ten years. A statement about an antibody threshold associated with longer protection should not be mistaken for observed long-term follow-up. The distinction connects a short-term booster result with the larger persistence question while making clear that the latter remains unresolved.
The tissue environment matters to the measured response
Chambers and colleagues examined a skin response to varicella-zoster antigen in older adults before and after vitamin D replacement. The clinical skin response improved overall, with individual variation. The study had no randomised placebo group, so it could not securely isolate the treatment effect. Nor did the result establish protection against shingles.
This supplies a link to Vitamin D and Immune Ageing: a response to previous immune experience is expressed in a tissue environment that may change with age. It does not show that every part of immune memory has improved. Early defence, introduced in Vitamin D and Innate Immunity, also interacts with targeted responses, but an innate marker is not itself a measure of antigen-specific memory.
A longer observation does not remove the model boundary
Yuzefpolskiy’s mouse experiment followed memory-related responses to a later time point and found reduced response diversity in animals lacking the vitamin D receptor. A receptor is a protein through which a signal acts. Removing it throughout a mouse’s life is different from supplementing a person whose blood vitamin D is low. The longer animal observation cannot be relabelled a human supplementation result.
Together, these examples show the connection and the gap. First responses can lead to later recall, and recall can be studied during ageing. But evidence at one stage does not automatically establish an effect at every later stage. The detailed comparison is in Vitamin D, Immune Memory Formation and Recall Across Age: Full Evidence Review.
Sources
Related reading
Post-Polio Syndrome: Impact of Humoral Immune Deficiencies, Poliovirus Neutralizing Antibodies, Vitamin D Deficiency
This study investigated susceptibility factors that may contribute to Post-Polio Syndrome (PPS) in elderly polio survivors.
Original paper ↗Read more →Vitamin D3 replacement enhances antigen-specific immunity in older adults
We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).
Original paper ↗Read more →Vitamin D, Immune Memory Formation and Recall Across Age: Full Evidence Review
How vitamin D studies distinguish vaccine responses, memory cells, recall and ageing, and why short-term findings do not establish lasting protection.
Read more →Vitamin D, Immune Memory Formation and Recall Across Age: Study Summary
A plain-English guide to vitamin D, vaccination, immune recall and ageing.
Read more →Vitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Full Evidence Review
A review of B-cell experiments and vaccine trials, separating memory-cell markers and antibody changes from lasting protection against infection.
Read more →Vitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Study Summary
Understand B-cell and vaccine findings, including null results, and why antibody changes do not establish durable protective immune memory.
Read more →Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study
In this nationwide, population-based cohort study involving 9,258,803 individuals, we aim to determine whether the incidence of AI-CTDs is associated with mRNA vaccination.
Original paper ↗Read more →Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patients
IgG titers served to classify participants as responders or non-responders and to calculate sensitivity, specificity, and accuracy.
Original paper ↗Read more →Suboptimal Consumption of Relevant Immune System Micronutrients Is Associated with a Worse Impact of COVID-19 in Spanish Populations
Coronavirus disease 2019 (COVID-19) has caused a global health crisis and the factors behind its differential impact on COVID-19 among populations are still being known.
Original paper ↗Read more →Association between Vitamin D Serum Levels and Immune Response to the BNT162b2 Vaccine for SARS-CoV-2
The use of micronutrients such as vitamin D could improve the response to viral vaccines, particularly in immunosuppressed and immunosenescent subjects.
Original paper ↗Read more →Factors Associated with Impaired Humoral Immune Response to mRNA Vaccines in Patients with Inflammatory Bowel Disease: A Matched-Cohort Analysis from the RisCoin Study
At baseline, IBD patients treated with anti-TNF but not those under vedolizumab or ustekinumab therapy had lower anti-spike levels compared to HCW-healthy and HCW-plus (166 versus 1384 and 1258 BAU/mL, respectively; p < 0.0001).
Original paper ↗Read more →IFN-β therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responses
IFN-β effects after therapy washout were compared to 15 therapy-naïve stable and 13 active RRMS and 18 healthy controls (HC).
Original paper ↗Read more →Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial
This randomized placebo-controlled double-blind trial investigated whether Vit-D supplementation in deficient elderly persons could improve influenza seroprotection and immune response.
Original paper ↗Read more →Short-term and long-term effects of vitamin D supplementation for preterm infants: a systematic review and meta-analysis
Meta-analysis conducted to evaluate the effectiveness of high-dose (≥800 IU/day) and low-dose (.
Original paper ↗Read more →Short-Term Fluctuation and Long-Term Stability of Vitamin D Status: Full Study
Full evidence review of how vitamin D levels fluctuate across seasons while retaining measurable longer-term stability within individuals.
Read more →Short-Term Fluctuation and Long-Term Stability of Vitamin D Status: Study Summary
Study summary explaining how vitamin D levels fluctuate seasonally while still showing measurable longer-term stability.
Read more →Short-Term vs Long-Term Vitamin D Status
Explore the difference between short-term and long-term vitamin D status, what influences changes over weeks versus months, how tests reflect timeframes, and why trends matter more than single values.
Read more →Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination
Baseline measurements of vitamins A and D were obtained from all participants.
Original paper ↗Read more →Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients
We evaluated the booster effect of the third dose (D3) of two SARS-CoV-2 mRNA vaccines 6 months after the second dose (D2) in Japanese KTR.
Original paper ↗Read more →The Expressions of the Immunity: and Muscle Development-Related Genes of 40-Day-Old Broilers Are Promoted in Response to the In Ovo and Dietary Supplemental Administration of Calcidiol in Conjunction with the In Ovo Administration of Marek’s Disease Vaccine †
The purpose of the current study was to identify the impacts of supplemental 25(OH)D3 administered dietarily or by in ovo injection in conjunction with the in ovo delivery of Marek’s Disease vaccine (MVD), on the expression of genes in the spleen and pectoralis major (P.
Original paper ↗Read more →Vitamin D and Adaptive Immunity
Learn how vitamin D relates to adaptive immunity, including its roles in T cells, B cells, antigen presentation, cytokine signalling, and immune memory.
Read more →Original sources
Vitamin D and the hepatitis B vaccine response: a prospective cohort study and a randomized, placebo-controlled oral vitamin D3 and simulated sunlight supplementation trial in healthy adults
Kashi et al. (2021). Vitamin D and the hepatitis B vaccine response: a prospective cohort study and a randomized, placebo-controlled oral vitamin D3 and simulated sunlight supplementation trial in healthy adults.
Publication details
Kashi et al. (2021). Vitamin D and the hepatitis B vaccine response: a prospective cohort study and a randomized, placebo-controlled oral vitamin D3 and simulated sunlight supplementation trial in healthy adults. European Journal of Nutrition. 60(1):475. DOI: 10.1007/s00394-020-02261-w.
Efficient tetanus toxoid immunization on vitamin D supplementation
Published in European journal of clinical nutrition. 65(3):329-334. DOI: 10.1038/ejcn (2010).
Publication details
Heine et al. (2011). Efficient tetanus toxoid immunization on vitamin D supplementation. European journal of clinical nutrition. 65(3):329-334. DOI: 10.1038/ejcn.2010.276.
Vitamin D3 replacement enhances antigen-specific immunity in older adults
We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).
Publication details
Chambers et al. (2021). Vitamin D3 replacement enhances antigen-specific immunity in older adults. Immunotherapy Advances. 1(1):ltaa008. DOI: 10.1093/immadv/ltaa008.
Vitamin D Receptor Signals Regulate Effector and Memory CD8 T Cell Responses to Infections in Mice
Yuzefpolskiy et al. (2014).
Publication details
Yuzefpolskiy et al. (2014). Vitamin D Receptor Signals Regulate Effector and Memory CD8 T Cell Responses to Infections in Mice. The Journal of nutrition. 144(12):2073-2082. DOI: 10.3945/jn.114.202895.